-+ 0.00%
-+ 0.00%
-+ 0.00%
Ensysce Biosciences to Participate in UBS, Piper Sandler Healthcare Conferences
Share
Listen to the news
Ensysce Biosciences to Participate in UBS, Piper Sandler Healthcare Conferences
  • Ensysce Biosciences will participate in two investor conferences through management of recently acquired Cy Biopharma.
  • UBS Healthcare Therapeutics Conference fireside chat in London: November 17, 2026, 2:40-3:10 p.m. GMT (9:40-10:10 a.m. ET).
  • 38th Annual Piper Sandler Healthcare Conference presentation in New York: December 3, 2026, 2:10-2:30 p.m. ET.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202611161615ACCESSWRNAPR_____1252080) on November 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending